Clinical trial
Randomized, Controlled Pilot Trial of Domperidone in Relapsing-Remitting Multiple Sclerosis
NCT02493049 is registered in ClinicalTrials.gov with University of Calgary as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomized, Controlled Pilot Trial of Domperidone in Relapsing-Remitting Multiple Sclerosis
- Lead sponsor
- University of Calgary
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- August 31, 2015
- Completion date
- February 28, 2019
- Enrollment
- 17 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.